Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preclinical research
Biotech
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK has tapped Oxford BioTherapeutics to discover new cancer antibodies.
Darren Incorvaia
Dec 10, 2025 11:15am
Denali ph. 1 Pompe plans hit with clinical hold
Dec 4, 2025 11:52am
Sanofi inks pact with Canadian tech company to bring AI to R&D
Oct 8, 2025 12:13pm
Biogen discontinues all AAV gene therapy work
Sep 26, 2025 11:04am
Rome nears end of road with planned layoffs, strategic review
Sep 23, 2025 2:00pm
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
